BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15755682)

  • 1. PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.
    Corbeil-Girard LP; Klein AF; Sasseville AM; Lavoie H; Dicaire MJ; Saint-Denis A; Pagé M; Duranceau A; Codère F; Bouchard JP; Karpati G; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2005 Apr; 18(3):551-67. PubMed ID: 15755682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
    Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
    Wang Q; Mosser DD; Bag J
    Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
    Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
    Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
    Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.
    Dion P; Shanmugam V; Gaspar C; Messaed C; Meijer I; Toulouse A; Laganiere J; Roussel J; Rochefort D; Laganiere S; Allen C; Karpati G; Bouchard JP; Brais B; Rouleau GA
    Neurobiol Dis; 2005 Apr; 18(3):528-36. PubMed ID: 15755680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions.
    Villagra NT; Bengoechea R; Vaqué JP; Llorca J; Berciano MT; Lafarga M
    Mol Cell Neurosci; 2008 Mar; 37(3):622-33. PubMed ID: 18255312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
    Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
    Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.
    Berciano MT; Villagra NT; Ojeda JL; Navascues J; Gomes A; Lafarga M; Carmo-Fonseca M
    Hum Mol Genet; 2004 Apr; 13(8):829-38. PubMed ID: 14976164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
    Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
    Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
    Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
    RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.
    Banerjee A; Phillips BL; Deng Q; Seyfried NT; Pavlath GK; Vest KE; Corbett AH
    J Biol Chem; 2019 May; 294(18):7360-7376. PubMed ID: 30837270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
    García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
    J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.